Background Glucocorticoids play an important role in the
A cute lymphoblastic leukemia is the most common leukemia in children less than 15 leukemia cases. 1 The five-year event-free developing countries the cure rate is reported to be Factors that play a role in the therapy failure in these countries are late diagnosis, high rates of relapse, drug withdrawal, death due to drug side effects, lack of supportive therapy, and the presence of the induction phase of post-remission chemotherapy or due to complications related to chemotherapy. 8, 9 High-dose glucocorticoids play an important role in ALL treatment, but can cause disturbances in the HPA axis, leading to atrophy of the adrenal cortex and resulting in secondary adrenal insufficiency. Suppression of the HPA axis causes adrenal insufficiency, disturbs the cortisol response to stress, and may be a cause of morbidity and mortality in children with ALL.
Adrenal insufficiency should be diagnosed early to avoid the risk of acute adrenal crisis. Currently there is little data on adrenal gland function after the administration of high-dose glucocorticoids in Indonesian children with ALL treated using the 2006 Indonesian Chemotherapy ALL Protocol.
Methods
newly diagnosed ALL were consecutively enrolled in the study. These patients came from several hospitals in Jakarta; those were Cipto Mangunkusumo Hospital, Harapan Kita Mother and Child Hospital, and Fatmawati Hospital. Acute lymphoblastic leukemia (ALL) was determined based on bone study protocol was approved by the Regional Ethics Committee and informed consent was obtained. Eleven children were excluded for the following not passing the initial adrenal function test (1 child), failure to complete the induction phase of chemotherapy until the end of the study (1 child), children. None had received glucocorticoid therapy for other disorders. Nine had standard-risk (SR) of ALL and 11 had high-risk (HR) of ALL.
The 
Results
Thirty-one children with newly-diagnosed ALL were Table 1 . years, completed the induction phase of chemotherapy and were evaluated in the study. Characteristics of the subjects can be seen in Table 1. standard dose ACTH stimulation test before starting the 5-week glucocorticoid therapy. Results of ACTH testing at 1 week after completion of induction chemotherapy revealed adrenal insufficiency in 14 Table 2 ). Statistical analysis revealed significant differences in both baseline cortisol levels and ACTHstimulated cortisol levels before induction chemotherapy compared to 1 week after completing therapy ( Table 3) .
After completion of induction chemotherapy and a week period of tapering off, all patients were examined for clinical signs of adrenal insufficiency such as malaise, anorexia, nausea, abdominal pain, fever, weight loss, and blood pressure. Laboratory results, including the post-induction ACTH stimulation test, are shown in Table 4 . No subjects showed any signs of acute adrenal crisis.
Discussion
The level of morning serum cortisol provides information about basal adrenocortical activity, but does not reflect the ability of the HPA axis to react to stress. Such ability can only be evaluated by determining the rise in serum cortisol in response to stimulation test is the most commonly used test to diagnose adrenal insufficiency. Peak cortisol levels 19 In contrast, glucocorticoids given to the subjects of our study was largely dexamethasone Petersen et al. 19 Furthermore, Petersen et al. 19 did not perform an ACTH stimulation test prior to chemotherapy, so their subjects' baseline adrenal gland function was not known. All study subjects adrenal insufficiency which may have contributed to the results. 19 et al., adrenal insufficiency was present in all patients for 4 weeks without a tapering off period. 18 Adrenal 4 weeks of dexamethasone discontinuation and all returned to normal after 8 weeks of dexamethasone discontinuation. 18 To date, there is no consensus on the cortisol level that describes an adequate adrenal response to stress or indicates adrenal insufficiency. In our study, we found a significant decrease in median cortisol levels pre-and post-test, before and after chemotherapy (Table 3) . However, the median pretest cortisol (t cortisol (t ) obtained by Cunha et al. who reported a t for 4 weeks. Cortisol t levels after chemotherapy in both studies differed significantly from cortisol t levels before chemotherapy. Our subjects' t levels were higher than those of Cunha et al because our et al.
(minimum 1 year of age).
Pre-test (t ) and post-test (t ) cortisol levels before chemotherapy were significantly different between groups of adrenal insufficiency compared with those without adrenal insufficiency ( Table 4) . This illustrates that adrenal function or HPA axis was the same in all subjects before chemotherapy. After chemotherapy, pre-test cortisol levels (t ) and post-test cortisol levels (t ) differed significantly between the groups. A similar trend was reported by Mahachoklertwattana et al., but with a higher median pre-test cortisol (t ) level than in our subjects.
We observed that adrenal insufficiency tended to occur in children of younger age, including
In contrast, Mahachoklertwattana et al. reported the incidence of adrenal insufficiency occurred more years. In addition, the adrenal gland recovery time
We found adrenal insufficiency to be more common in male than in female subjects. This observation was not made in other studies, possibly because most of our subjects were boys. Risk group and type of steroid given were not related to adrenal insufficiency, consistent with others' results.
Some subjects had non-specific symptoms of steroid withdrawal syndrome such as fatigue, anorexia, nausea, vomiting, abdominal pain, and fever, but these symptoms did not significantly differ between those with and without adrenal insufficiency. Most subjects experienced weight gain, similar to a study by Felner et al. 18 who reported that central obesity weight gain and visible signs of central obesity, buffalo hump, and moon face. Hypertension is a side reported in children with ALL after completing chemotherapy. This side effect is not related to age, sex, leukocyte count, risk group, body mass index, or serum creatinine level.
One subject who experienced hyperglycemia also had significant weight gain after chemotherapy and showed signs of central obesity, buffalo hump, and moon face. The glucocorticoid dose given to this subject was based on ideal weight, not actual weight. Hyperglycemia may have occurred due to the glucocorticoid effect on carbohydrate and protein metabolism. Glucocorticoids stimulate gluconeogenesis in the liver and increase protein lysis and lipolysis, thereby increasing blood glucose levels. Baillargeon et al. reported that the incidence of transient hyperglycemia during the induction phase Transient hyperglycemia is more likely to occur in or obese nutritional status and a history of diabetes mellitus in the family. The hyperglycemic boy in our study was 9 years old, obese, and experienced a induction phase, but he did not have a family history of diabetes mellitus.
We found that the levels of hemoglobin, leukocytes, and platelets were significantly higher in the group with adrenal insufficiency than in the group without adrenal insufficiency ( Table 4) . Blood tests were performed 1 week after the last dose of glucocorticoids and in conjunction with the second adrenal function tests. All subjects had anemia, presumably related to the lack of food intake after cessation of glucocorticoids. No subject received blood transfusions within a week prior to blood tests. These findings were not reported in other studies on adrenal function in children with ALL. To date, we have not find a link between adrenal function and changes in hemoglobin, leukocyte, and platelet levels.
This study supports the findings of previous studies that adrenal insufficiency is often found in children with ALL who undergo chemotherapy with glucocorticoids. Our study was conducted in four referral hospitals in Jakarta, so results are representive of the pediatric ALL population in Indonesia. All subjects had normal adrenal function before chemotherapy and served as their own control, therefore, we may exclude any cause for adrenal insufficiency after chemotherapy other than glucocorticoids.
adrenal insufficiency after receiving glucocorticoids during the induction phase of chemotherapy, despite a week period of tapering off. There is a statistically significant decrease in median pre-test and post-test cortisol levels before and after chemotherapy in pediatric ALL subjects who complicated the induction phase of chemotherapy. Clinical signs and symptoms, such as fatigue, anorexia, nausea, vomiting, abdominal pain, fever, and weight loss, were not related to adrenal insufficiency.
A large-scale study, with a longer observation period and performance of serial ACTH stimulation tests, is needed to further clarify the mechanism and duration of adrenal insufficiency, determine the magnitude of the problem, and assess the need for glucocorticoid replacement therapy in children with ALL who receive high doses of glucocorticoids during chemotherapy. Physicians who treat pediatric patients with high-dose glucocorticoids for more adrenal insufficiency and test basal cortisol levels in the morning.
